HomeHeroesDe NovoDiscoveryGene ScanCDx Pathwayโ™ป๏ธ Repurposing๐Ÿšฆ GatesModelsQuantum๐Ÿงช Wet LabSchedules๐ŸŽ›๏ธ Control๐Ÿงฌ CIFOG๐Ÿ“ˆ Milestones๐Ÿงฌ BioBrain๐Ÿง  NPEADArchitecture๐Ÿ”ฌ RODE๐Ÿง  Cortex-RWorkspace๐Ÿง  V2๐Ÿง  V3๐Ÿ“ฆ Knowledge๐Ÿ’ฐ Revenue๐Ÿ“Š Costs๐Ÿ“š Datasets

๐Ÿšฆ Pipeline Gates โ€” Quality Control

Monotone cost escalation. Cheapest first. Every compound earns the right to the next gate. Updated June 20, 2026.

Active Gate System (gpu-batch-rs)

GateNamePass ConditionFail ActionCostStage
G0SMILES ValidityRDKit parse + sanitize succeedsDROP$0CPU
G1Structural AlertsNo PAINS + no reactive groups + no 30 med-chem patterns (Brenk/Lilly)DROP$0CPU
G2Drug-LikenessMW 200โ€“600, QED โ‰ฅ 0.3, โ‰ค 10 rotatable bonds, Lipinski โ‰ค 1 violationDROP$0CPU
G3Atom FilterOnly C, N, O, F, P, S, Cl, Br โ€” no exotic atomsDROP$0CPU
G4Docking (Uni-Dock)Vina โ‰ค -6.5 kcal/mol (LE-adjusted)REJECT~$0.05GPU
G5Pose Consensusโ‰ฅ 1 valid pose within pocket, variance < thresholdFLAG$0GPU
G6NPEAD Scoringadvancement_score > threshold (learned, adaptive per target)REJECT$0CPU
G7Chemistry ValidationNo CRITICAL flags, SA < 6.0, no reactivity alertsGRADE CAP$0CPU (nightly)
G8Evidence ChainHash-linked audit trail valid, all prior decisions recordedHOLD$0CPU

Chemistry Danger Patterns (30 rules โ€” G1)

#PatternSourceRisk
1-8Reactive electrophiles (acyl halides, Michael acceptors, epoxides, isocyanates...)Brenk 2008Covalent modification
9-16Aggregators + PAINS (rhodanines, catechols, quinones, hydroxamic acids...)Lilly 2012False positives
17-24Metabolic liabilities (nitros, anilines, hydrazines, alkyl halides...)ChEMBL curationToxicity / instability
25-30Privileged but risky (thiol warheads, boronic acids, peroxides...)MindNetQ customContext-dependent

NPEAD Gate Learning (Adaptive โ€” G6)

Gate thresholds are not fixed. NPEAD Phase 9 learns from outcomes:

Capsule Influence on Gates

Capsule SignalGate Effect
Chemistry (Best Vina โ‰ค -8.0)Generator tightens โ†’ fewer candidates reach G4, but higher pass rate
Safety (all clear)G1 thresholds maintained โ€” current patterns work
Evidence (weak)Generator explores more โ†’ more diversity at G2, lower average but wider search
Transcriptomics (many dysregulated)Prioritization signal โ€” more GPU budget allocated to these targets

Cost Escalation Path

  CPU ($0)          G0 โ†’ G1 โ†’ G2 โ†’ G3 โ†’ G6 โ†’ G7 โ†’ G8     (kills ~80% of candidates)
       โ”‚
       โ–ผ
  GPU (~$0.05/mol)  G4 โ†’ G5                                  (kills ~50% of survivors)
       โ”‚
       โ–ผ
  Quantum ($330+)   VQE binding confirmation                  (only A+ heroes, PI-approved)
       โ”‚
       โ–ผ
  Wet-Lab ($15K+)   Human gate + budget + CRO                 (final survivors only)

Grade Assignment (post-gate)

GradeCriteriaMeaning
A+Vina โ‰ค -8.5, validated, all gates passPreclinical candidate
AVina โ‰ค -7.5, validatedStrong hit
B+Vina โ‰ค -6.5, dockedPromising โ€” needs optimization
BVina > -6.5, dockedWeak โ€” scaffold hop needed
CAll molecules failed gatesTarget needs different approach

Governance Rules

RuleEnforcement
Monotone cost escalationCheapest gates always first โ€” never spend GPU on what fails CPU
No grade inflationnext-action-rs checks for pipeline bugs before any downgrade; CDK9 stays A (PI decision)
FRSI is advisoryWEAK_FRSI does not block generation โ€” it's informational
Per-gene dedupMax 3 GPU jobs per gene (watchdog enforces)
No on-demand GPUAll Spot โ€” no spending without PI approval
Evidence chainEvery gate decision SHA-256 hash-linked, tamper-evident
Quantum gate = human-approvedVQE only fires after explicit PI approval + budget
No downgrade without bug checkSystem checks for error/timeout/OOM/spot before any grade reduction

Live Gate Performance

Loading...

MindNetQ Inc. ยท Pipeline Gates v3 ยท Evidence-governed drug discovery